Drugs / H1N1 pandemic influenza vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00976469 | Sep 2009 → Apr 2010 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Phase 1/2 | NCT00959465 | Aug → Nov 2009 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H1N1 pandemic influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00959465 ↗ |
| Modality | Vaccine | “H1N1 pandemic influenza vaccine” NCT00959465 ↗ |
| Route | Intramuscular | “intramuscular injection in either the upper arm or thigh, depending on the subject´s age” NCT00976469 ↗ |